The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity by GBIResearch

VIEWS: 327 PAGES: 54

More Info
									         The Future of High Potency Active Pharmaceutical
        Ingredients (HPAPIs), Market Forecasts and Growth
     Opportunities to 2015 - Growing Demand Drives Investment
                             in Capacity
     Reference Code: GBICH0020MR                                                                              Publication Date: March 2010

  The global HPAPI market            High potency compounds are the fastest growing segment of the active pharmaceutical ingredients
  is set to grow at a CAGR           market worldwide. The global pharmaceutical industry is increasingly realizing the strong
  of 8.4% from 2009 to 2015          therapeutic potential of high potency active pharmaceutical ingredients (HPAPIs). The high potency
                                     market is set to witness a strong growth rate in the forecast period between 2009 and 2015 with
                                     many companies poised for massive expansions of their facilities for the production of high potency
                                     active pharmaceutical compounds.
                                     The Global High Potency Active Pharmaceutical Ingredients Market is Poised for High
                                     Growth in the Forecast Period.
                                     Due to the growing targeted therapy approach in the treatment of diseases, the demand for high
                                     potency APIs is increasing fast. The major therapeutic application of these compounds is in
                                     oncology drugs. As oncology is the fastest growing therapeutic segment in the pharmaceutical
                                     industry, it is driving the high potency market worldwide.
                                     Growth in oncology in the coming years, together with the increasing usage of high potency APIs in
                                     other therapies, is going to be major driver for the global market of high potency active
                                     pharmaceutical ingredients in the coming five years. The global high potency active pharmaceutical
                                     ingredients market is set to grow at a CAGR of 8.4% from 2009 to 2015.

                                       Global HPAPI Market, Revenue Forecasts, 2009-2015

                                                              14

                                                                                                                          12.1
                                                              12



                                                              10
                                            Revenues ($ bn)




                                                               8                            7.5


                                                                   5.9
                                                               6



                                                               4



                                                               2



                                                               0
                                                                   2005                    2009                          2015
                                                                                           Years


                                       Source: GBI Research



                                     The Global High Potency Active Pharmaceutical Ingredients Market is Governed by the
                                     Branded Sector
                                     The use of high potency active pharmaceutical ingredients is a comparatively new and growing
                                     concept in the global pharmaceutical industry. This market is dominated by patented high potency

The Future of High Potency Active Pharmaceutical Ingredients                                               GBICH0020MR /Published MAR 2010
(HPAPIs), Market Forecasts and Growth Opportunities to 2015 -
Growing Demand Drives Investment in Capacity                                                                                             Page 1
                                                                          © GBI Research. This is a licensed product and is not to be photocopied
                                     drugs by the innovators. Hence, the branded sector holds a major share of the total high potency
                                     market. The generic sector has a small share, but it is set to grow as the branded highly potent
                                     drugs will go off patent in the years to come.

                                       Global HPAPI Market, Revenue Share Analysis By Types Based On Customer Base,
  North America and                             2009
  Europe together hold
  more than 80% of the
  global HPAPI market
                                                              Generic HPAPI
                                                                  19%




                                                                                                             Branded HPAPI
                                                                                                                  81%




                                       Source: GBI Research



                                     North America and Europe Together Hold More Than Eighty Percent of the Global High
                                     Potency APIs Market
                                     North America accounts for the majority of the global high potency market. Most of the world’s
                                     pharmaceutical research and development is carried out in the North American region. This is
                                     followed by the European region. A large number of discoveries of new high potency compounds
                                     are being made in Europe. The pharmaceutical industry in North America and Europe is highly
                                     regulated and advanced in terms of the acceptance and adaptability of new therapies.
                                     North America’s share of the global high potency active pharmaceutical ingredients market for the
                                     year 2009 was close to 45.6%. This accounted for $3.4 billion in terms of market revenues. The
                                     share of the US in the North American high potency API market is dominant, whereas Canada is
                                     only a small market.
                                     The European market for high potency compounds held 35% of the global market, which
                                     accounted for $2.6 billion in market revenues in 2009. The major markets in the European region
                                     are the UK, Germany, France, Italy and Spain. The Western European countries hold a majority
                                     share in the European high potency API market. However, the Eastern European countries are fast
                                     growing markets.




The Future of High Potency Active Pharmaceutical Ingredients                                                   GBICH0020MR /Published MAR 2010
(HPAPIs), Market Forecasts and Growth Opportunities to 2015 -
Growing Demand Drives Investment in Capacity                                                                                                 Page 2
                                                                              © GBI Research. This is a licensed product and is not to be photocopied
                                       Global HPAPI Market, Revenue Share Analysis By Geographies, 2009

                                                                                     Asia Pacific
                                                                                        9.3%
                                                                                                    Rest of the World
                                                                                                         10.1%


                                                                Europe
                                                                35.0%




                                                                                                    North America
                                                                                                        45.6%


                                       Source: GBI Research



                                     Asia Pacific is the Fastest Growing Market for High Potency Active Pharmaceutical
                                     Ingredients
                                     The healthcare standards in the Asia Pacific region are rising very fast as the economies in that
                                     region are growing. The acceptance and adaptability towards new drugs and therapies is also
                                     growing in the Asia Pacific countries. As a result, the region shows the fastest growth rates in the
                                     high potency market. In 2009, the Asia Pacific region held a share of 9.3% in the global high
                                     potency active pharmaceutical ingredients market. This accounted for $0.7 billion in terms of
                                     market sales revenues. Japan holds a dominant share in the Asia Pacific high potency API market
                                     and is the fastest growing market. The Indian and Chinese markets are closely following Japan with
                                     high growth rates.
                                     The Rest of the World held a 10.1% share of the global HPAPIs market in 2009. Some countries in
                                     the Rest of the World are also growing very fast as markets for high potency active pharmaceutical
                                     ingredients.
                                     High Potency        Active Pharmaceutical Ingredients Segment Has                   Attractive Growth
                                     Opportunities
                                     With high growth rates, the high potency API segment is showing attractive growth opportunities for
                                     the pharmaceutical companies. A number of companies, recognizing the strong growth potential,
                                     are expanding their facilities for the production of HPAPIs. Also, a number of contract
                                     manufacturers are coming up with high potency manufacturing capabilities. There is an increasing
                                     trend of contract manufacturing being used in the high potency segment. The high potency API
                                     global market is relatively less competitive and the demand is much more than the supply. The
                                     competition is going to increase in the coming ten years.




The Future of High Potency Active Pharmaceutical Ingredients                                              GBICH0020MR /Published MAR 2010
(HPAPIs), Market Forecasts and Growth Opportunities to 2015 -
Growing Demand Drives Investment in Capacity                                                                                            Page 3
                                                                         © GBI Research. This is a licensed product and is not to be photocopied
                                     1         Table of Contents
                                     1    Table of Contents .................................................................................................................... 4
                                       1.1      List of Tables.................................................................................................................. 7
                                       1.2      List of Figures................................................................................................................. 8
                                     2    Introduction .............................................................................................................................. 9
                                       2.1      GBI Report Coverage..................................................................................................... 9
                                       2.2      Definitions ...................................................................................................................... 9
                                     3    Global High Potency Active Pharmaceutical Ingredients Market ........................................... 10
                                       3.1      Introduction to High Potency Active Pharmaceutical Ingredients ................................. 10
                                          3.1.1     Category 1: Low Potency ........................................................................................ 10
                                          3.1.2     Category 2: Moderate Potency................................................................................ 10
                                          3.1.3     Category 4: High Potency........................................................................................ 10
                                       3.2      Global HPAPI Industry Structure.................................................................................. 11
                                       3.3      Global HPAPI Industry Challenges .............................................................................. 12
                                          3.3.1     Requirement of Large Investments ......................................................................... 12
                                          3.3.2     Requirement of Specialized Manufacturing Facilities .............................................. 12
                                          3.3.3     Necessity of Very Specific Safety and Handling Requirements............................... 12
                                          3.3.4     Need for Tougher Industry Standards ..................................................................... 12
                                       3.4      Global HPAPI Market Overview ................................................................................... 13
                                       3.5      Global HPAPI Market Drivers....................................................................................... 13
                                          3.5.1     The Growth in the Global Anti-Cancer Market is the Major Force Behind the
                                          Growing Demand for HPAPIs in the World ............................................................................ 13
                                          3.5.2     The Growth of the Targeted Therapy Approach is Driving the Demand for HPAPIs13
                                          3.5.3     Increasing Number of Applications of HPAPIs is Contributing to Increase in the
                                          Demand for HPAPIs Worldwide............................................................................................. 13
                                       3.6      Global HPAPI Market Restraints .................................................................................. 14
                                          3.6.1     The Global Economic Slowdown is Restricting the Growth of the HPAPI Market ... 14
                                          3.6.2     Conservative Approach Towards the Acceptance of New and Expensive Drugs is
                                          Seen to be a Hindrance to the Growth of the Global HPAPI Market...................................... 14
                                          3.6.3     Very High Potency May Create a Roadblock to the Growth of Some HPAPIs ........ 14
                                       3.7      Global HPAPI Market Revenue Forecasts, 2005-2015 ................................................ 14
                                       3.8      Global HPAPI Product Types ....................................................................................... 15
                                          3.8.1     Types Based on Synthesis Route ........................................................................... 15
                                          3.8.2     Types Based On Customer Base ............................................................................ 16
                                       3.9      Global HPAPI Market Revenue Share Analysis By Geographies ................................ 18
                                       3.10     Global HPAPI Market Revenue Share Analysis by Therapeutic Applications .............. 19
                                       3.11     Global HPAPI Market Opportunity Analysis ................................................................. 20
                                          3.11.1       Strategic Advances in the High Potency Segment.............................................. 20
                                          3.11.2       Scope for Differentiation in the HPAPI Market .................................................... 21
                                     4    North America High Potency Active Pharmaceutical Ingredients Market............................... 22
                                       4.1      North America HPAPI Market Overview....................................................................... 22
                                       4.2      North America HPAPI Market Drivers .......................................................................... 22
                                          4.2.1     Growth in Oncology is the Major Contributing Factor for the Growth of HPAPI
                                          Demand in the Region ........................................................................................................... 22
                                          4.2.2     Increasing Demand for Antibody Drug Conjugates in the Region Facilitates the
                                          Growth in HPAPI Demand ..................................................................................................... 22
                                          4.2.3     The Growth of Lifestyle Diseases and Older Age Diseases is Driving the Demand
                                          for HPAPI in the Region......................................................................................................... 22
                                          4.2.4     Increasing Number of Applications is Leading to Higher HPAPI Demand in the
                                          Region 22
                                          4.2.5     Large Untapped Market Potential will Increase the HPAPI Market Growth Rate..... 22
                                          4.2.6     Less Competition from Other Regions Helps the HPAPI Market to Grow In North
                                          America 23
                                       4.3      North America HPAPI Market Restraints...................................................................... 23



The Future of High Potency Active Pharmaceutical Ingredients                                                                        GBICH0020MR /Published MAR 2010
(HPAPIs), Market Forecasts and Growth Opportunities to 2015 -
Growing Demand Drives Investment in Capacity                                                                                                                                 Page 4
                                                                                        © GBI Research. This is a licensed product and is not to be photocopied
                                          4.3.1      Economic Slowdown is Restricting the Growth of the HPAPI Market in North
                                          America 23
                                          4.3.2      Stringent Cost-Benefit Analysis by Authorities is a Hindrance to the Growth of the
                                          HPAPI Market. ....................................................................................................................... 23
                                       4.4       North America HPAPI Market Revenue Forecasts....................................................... 23
                                       4.5       North America HPAPI Market Revenue Share Analysis by Product Types.................. 24
                                       4.6       North America HPAPI Market Revenue Share Analysis By Countries ......................... 25
                                       4.7       North America HPAPI Market Competitive Landscape ................................................ 25
                                       4.8       The US High Potency Active Pharmaceutical Ingredients Market................................ 27
                                          4.8.1      The US HPAPI Market Overview............................................................................. 27
                                          4.8.2      The US HPAPI Market Revenue Forecasts............................................................. 27
                                       4.9       Canada High Potency Active Pharmaceutical Ingredients Market ............................... 28
                                          4.9.1      Canada HPAPI Market Overview ............................................................................ 28
                                          4.9.2      Canada HPAPI Market Revenue Forecasts ............................................................ 28
                                     5    Europe High Potency Active Pharmaceutical Ingredients Market .......................................... 30
                                       5.1       Europe HPAPI Market Overview .................................................................................. 30
                                       5.2       Europe HPAPI Market Drivers...................................................................................... 30
                                          5.2.1      Growth in Oncology is the Major Force Behind the Growing HPAPI Demand in
                                          Europe 30
                                          5.2.2      The Increasing Incidence of Lifestyle and Older Age Diseases in Europe is Giving
                                          Rise to Demand for HPAPIs .................................................................................................. 30
                                          5.2.3      The Growth in the Market for Antibody Drug Conjugates in the Region Strongly
                                          Facilitates the Growth of the HPAPI Market........................................................................... 30
                                          5.2.4      Growth in the Number of HPAPI Applications is Widening the Market Demand in the
                                          Region 30
                                          5.2.5      Less Competition from Other Regions Helps the HPAPI Market Grow in Europe ... 30
                                       5.3       Europe HPAPI Market Restraints................................................................................. 31
                                          5.3.1      The Downturn in the Economy Restricts the Growth of the HPAPI Market in the
                                          Region 31
                                          5.3.2      Stricter Analyses of the Cost-Benefit Ratios of Drugs by Regulatory Authorities is
                                          Becoming an Obstacle to the Growth of the HPAPI Market in the Region............................. 31
                                          5.3.3      Very High Potency of Some HPAPI Compounds May Adversely Affect the Growth in
                                          the Region ............................................................................................................................. 31
                                       5.4       Europe HPAPI Market Revenue Forecasts .................................................................. 31
                                       5.5       Europe HPAPI Market Revenue Share Analysis By Product Types............................. 32
                                       5.6       Europe HPAPI Market Revenue Share Analysis By Countries .................................... 33
                                       5.7       Europe HPAPI Market Competitive Landscape............................................................ 34
                                       5.8       The UK High Potency Active Pharmaceutical Ingredients Market................................ 35
                                          5.8.1      The UK HPAPI Market Overview............................................................................. 35
                                          5.8.2      The UK HPAPI Market Revenue Forecasts............................................................. 35
                                       5.9       Germany High Potency Active Pharmaceutical Ingredients Market ............................. 37
                                          5.9.1      Germany HPAPI Market Overview .......................................................................... 37
                                          5.9.2      Germany HPAPI Market Revenue Forecasts .......................................................... 37
                                       5.10      France High Potency Active Pharmaceutical Ingredients Market................................. 38
                                          5.10.1        France HPAPI Market Overview ......................................................................... 38
                                          5.10.2        France HPAPI Market Revenue Forecasts......................................................... 38
                                       5.11      Italy High Potency Active Pharmaceutical Ingredients Market ..................................... 39
                                          5.11.1        Italy HPAPI Market Overview ............................................................................. 39
                                          5.11.2        Italy HPAPI Market Revenue Forecasts ............................................................. 40
                                       5.12      Spain High Potency Active Pharmaceutical Ingredients Market................................... 41
                                          5.12.1        Spain HPAPI Market Overview ........................................................................... 41
                                          5.12.2        Spain HPAPI Market Revenue Forecasts........................................................... 41
                                     6    Asia Pacific High Potency Active Pharmaceutical Ingredients Market ................................... 43
                                       6.1       Asia Pacific HPAPI Market Overview ........................................................................... 43
                                       6.2       Asia Pacific HPAPI Market Drivers............................................................................... 43



The Future of High Potency Active Pharmaceutical Ingredients                                                                       GBICH0020MR /Published MAR 2010
(HPAPIs), Market Forecasts and Growth Opportunities to 2015 -
Growing Demand Drives Investment in Capacity                                                                                                                               Page 5
                                                                                       © GBI Research. This is a licensed product and is not to be photocopied
                                          6.2.1     Strongly Growing Economies and Increasing Healthcare Standards in the Asia
                                          Pacific Region Favours the Growth of HPAPI Demand ......................................................... 43
                                          6.2.2     Growth in Demand of Oncology Drugs is Driving the Demand of HPAPIs in Asia
                                          Pacific 43
                                          6.2.3     Growth in the Generic Sector HPAPIs..................................................................... 43
                                          6.2.4     The Growing Number of Producers in the Asia Pacific Region is Helping the HPAPI
                                          Market to Grow ...................................................................................................................... 43
                                       6.3       Asia Pacific HPAPI Market Restraints .......................................................................... 43
                                          6.3.1     Restricted Expenditure on New Drugs in the Asia Pacific Countries Forms a
                                          Restraint to the Growth of the HPAPI Market ........................................................................ 43
                                          6.3.2     Strict Government Policies of The Asian Countries Forms a Hurdle to the Market
                                          Growth of HPAPIs in the Asia Pacific Region ........................................................................ 44
                                       6.4       Asia Pacific HPAPI Market Revenue Forecasts ........................................................... 44
                                       6.5       Asia Pacific HPAPI Market Revenue Share Analysis by Product Types ...................... 45
                                       6.6       Asia Pacific HPAPI Market Revenue Share Analysis by Country................................. 46
                                       6.7       Asia Pacific HPAPI Market Competitive Landscape..................................................... 47
                                       6.8       Japan High Potency Active Pharmaceutical Ingredients Market .................................. 47
                                          6.8.1     Japan HPAPI Market Overview ............................................................................... 47
                                          6.8.2     Japan HPAPI Market Revenue Forecasts ............................................................... 47
                                       6.9       India High Potency Active Pharmaceutical Ingredients Market .................................... 48
                                          6.9.1     India HPAPI Market Overview ................................................................................. 48
                                          6.9.2     India HPAPI Market Revenue Forecasts ................................................................. 49
                                       6.10      China High Potency Active Pharmaceutical Ingredients Market................................... 50
                                          6.10.1       China HPAPI Market Overview........................................................................... 50
                                          6.10.2       China HPAPI Market Revenue Forecasts........................................................... 50
                                     7    Appendix................................................................................................................................ 52
                                       7.1       Methodology................................................................................................................. 52
                                          7.1.1     Coverage................................................................................................................. 52
                                          7.1.2     Secondary Research ............................................................................................... 53
                                          7.1.3     Primary Research.................................................................................................... 53
                                          7.1.4     Expert Panel Validation ........................................................................................... 53
                                       7.2       Units Of Measure ......................................................................................................... 53
                                       7.3       Contact Us ................................................................................................................... 53
                                       7.4       About GBI Research .................................................................................................... 53
                                       7.5       Disclaimer .................................................................................................................... 54




The Future of High Potency Active Pharmaceutical Ingredients                                                                       GBICH0020MR /Published MAR 2010
(HPAPIs), Market Forecasts and Growth Opportunities to 2015 -
Growing Demand Drives Investment in Capacity                                                                                                                               Page 6
                                                                                       © GBI Research. This is a licensed product and is not to be photocopied
                                     1.1     List of Tables
                                     Table 1:     API Potency Classification Scheme ............................................................................. 10
                                     Table 2:     Global HPAPI Market, Revenue Forecasts, 2005-2015 ............................................... 15
                                     Table 3:     Global HPAPI Market, Revenue Shares By Types Based On Synthesis Route, 2009. 16
                                     Table 4:     Global HPAPI Market, Revenue Share Analysis By Types Based On Customer Base,
                                     2009         17
                                     Table 5:     Global HPAPI Revenue Share Analysis By Geographies, 2009 .................................. 19
                                     Table 6:     Global HPAPI Market, Revenue Share Analysis By Therapeutic Applications............. 20
                                     Table 7:     North America HPAPI Market, Revenue Forecasts, 2005-2015................................... 24
                                     Table 8:     North America HPAPI Market, Revenue Share Analysis By Product Types, 2009 ...... 25
                                     Table 9:     North America HPAPI Market, Revenue Share Analysis By Countries, 2009 .............. 25
                                     Table 10:       North America HPAPI Market, Revenue Share Analysis By Companies, 2009....... 26
                                     Table 11:       The US HPAPI Market, Revenue Forecasts, 2005-2015......................................... 28
                                     Table 12:       Canada HPAPI Market, Revenue Forecasts, 2005-2015 ........................................ 29
                                     Table 13:       Europe HPAPI Market, Revenue Forecasts, 2005-2015 ......................................... 32
                                     Table 14:       Europe HPAPI Market, Revenue Share Analysis By Product Types, 2009 ............. 33
                                     Table 15:       Europe HPAPI Market, Revenue Share Analysis By Countries............................... 34
                                     Table 16:       Europe HPAPI Market, Revenue Share Analysis By Companies, 2009 .................. 35
                                     Table 17:       The UK HPAPI Market Revenue Forecasts, 2005-2015.......................................... 36
                                     Table 18:       Germany HPAPI Market Revenue Forecasts, 2005-2015 ....................................... 38
                                     Table 19:       France HPAPI Market, Revenue Forecasts, 2005-2015.......................................... 39
                                     Table 20:       Italy HPAPI Market Revenue Forecasts, 2005-2015 ............................................... 41
                                     Table 21:       Spain HPAPI Market Revenue Forecasts, 2005-2015............................................. 42
                                     Table 22:       Asia Pacific HPAPI Market Revenue Forecasts, 2005-2015 ................................... 45
                                     Table 23:       Asia Pacific HPAPI Market, Revenue Share Analysis By Product Types, 2009 ...... 46
                                     Table 24:       Asia Pacific HPAPI Market, Revenue Share Analysis By Country, 2009................. 47
                                     Table 25:       Japan HPAPI Market, Revenue Forecasts, 2005-2015 ........................................... 48
                                     Table 26:       India HPAPI Market, Revenue Forecasts, 2005-2015 ............................................. 50
                                     Table 27:       China HPAPI Market, Revenue Forecasts, 2005-2015 ........................................... 51




The Future of High Potency Active Pharmaceutical Ingredients                                                           GBICH0020MR /Published MAR 2010
(HPAPIs), Market Forecasts and Growth Opportunities to 2015 -
Growing Demand Drives Investment in Capacity                                                                                                               Page 7
                                                                               © GBI Research. This is a licensed product and is not to be photocopied
                                     1.2     List of Figures
                                     Figure 1: Global HPAPI Market, Value Chain, 2009.................................................................... 11
                                     Figure 2: Global HPAPI Market, Revenue Forecasts, 2005-2015 ............................................... 15
                                     Figure 3: Global HPAPI Market, Revenue Shares By Types Based On Synthesis Route, 2009. 16
                                     Figure 4: Global HPAPI Market, Revenue Share Analysis By Types Based On Customer Base,
                                     2009        17
                                     Figure 5: Global HPAPI, Product Types, 2009 ............................................................................ 18
                                     Figure 6: Global HPAPI Market, Revenue Share Analysis By Geographies, 2009 ..................... 18
                                     Figure 7: Global HPAPI Market, Revenue Share Analysis By Therapeutic Applications............. 20
                                     Figure 8: North America HPAPI Market, Revenue Forecasts, 2005-2015................................... 23
                                     Figure 9: North America HPAPI Market, Revenue Share Analysis By Product Types, 2009 ...... 24
                                     Figure 10:     North America HPAPI Market, Revenue Share Analysis By Countries, 2009 ......... 25
                                     Figure 11:     North America HPAPI Market, Revenue Share Analysis By Companies, 2009....... 26
                                     Figure 12:     The US HPAPI Market, Revenue Forecasts, 2005-2015......................................... 27
                                     Figure 13:     Canada HPAPI Market, Revenue Forecasts, 2005-2015 ........................................ 29
                                     Figure 14:     Europe HPAPI Market, Revenue Forecasts, 2005-2015 ......................................... 31
                                     Figure 15: Europe HPAPI Market, Revenue Share Analysis By Product Types, 2009.................... 32
                                     Figure 16: Europe HPAPI Market, Revenue Share Analysis By Countries, 2009 ........................... 33
                                     Figure 17:      Europe HPAPI Market, Revenue Share Analysis By Companies, 2009 ................. 35
                                     Figure 18:      The UK HPAPI Revenue Forecasts, 2005-2015 .................................................... 36
                                     Figure 19:      Germany HPAPI Market Revenue Forecasts, 2005-2015 ...................................... 37
                                     Figure 20:      France HPAPI Market, Revenue Forecasts, 2005-2015......................................... 39
                                     Figure 21:     Italy HPAPI Market Revenue Forecasts, 2005-2015 ............................................... 40
                                     Figure 22:      Spain HPAPI Market Revenue Forecasts, 2005-2015............................................ 42
                                     Figure 23: Asia Pacific HPAPI Market Revenue Forecasts, 2005-2015 .......................................... 44
                                     Figure 24:      Asia Pacific HPAPI Market, Revenue Share Analysis By Product Types, 2009 ..... 45
                                     Figure 25: Asia Pacific HPAPI Market, Revenue S
								
To top